In focus · trending topic

SPR741

18 stories · following the connections

Spero Therapeutics to Present at Bank of America Merrill Lynch Health Care Conference in May

By Nasdaq OMXMay 1, 2018, 1:02 PM UTC

Spero Therapeutics Highlights SPR741 Phase 1 and Preclinical Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases

By Nasdaq OMXApr 16, 2018, 12:01 PM UTC

Spero Therapeutics Appoints Ian A. Critchley, Ph.D., as Head of Clinical Microbiology

By Nasdaq OMXApr 12, 2018, 12:02 PM UTC

Spero Therapeutics Announces Fourth Quarter and Full Year 2017 Operating Results and Provides Pipeline Update

By Nasdaq OMXApr 2, 2018, 8:10 PM UTC

Spero Therapeutics to Present at Upcoming Investor Conferences

By Nasdaq OMXMar 22, 2018, 12:00 PM UTC

Spero Therapeutics to Present at March Investor Conferences

By Nasdaq OMXMar 1, 2018, 1:02 PM UTC

Spero Announces Appointment of David P. Southwell to its Board of Directors

By Nasdaq OMXFeb 1, 2018, 1:01 PM UTC

Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer

By Nasdaq OMXJan 4, 2018, 12:32 PM UTC